QS-21
N/A
Report date: 2026/04/22 20:01:10
NME
Base Information
Drug NameQS-21
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[20]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[11]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAgenus Inc
China Registration ClassN/A
Develop Information
Inactive CompaniesAgenus IncNational Cancer InstituteOhio State University Comprehensive Cancer Center +[4]
Active Indications
Inactive Indications +[19]